Ropes & Gray LLP

Ropes & Gray LLP routinely acts for global biopharmaceutical and medical device companies, as well as a large proportion of private equity investors. The practice houses experts in licensing, IP, disputes, China regulatory issues, M&A, and capital markets, as well as venture capital investments, equity financings, securities and public company matters. Other notable areas are human genetic regulation, data privacy and research compliance. Dividing his time between Shanghai and New York, Arthur Mok acts for biotechs, multinational pharmaceutical companies and investment sponsors on Greater China matters; and the track record of Eric Wu, who works across the firm’s Hong Kong and Shanghai offices, includes advising biotechnology, pharmaceutical, medical device and consumer healthcare companies, as well as venture capital, private equity and hedge funds.